NEJM 2023 Mayo Clinic: GLP-1 Agonists for Weight Loss Treatments related to this article Ready to talk through this with a provider
Frequently Asked Questions What does it mean that the medication comes from a licensed 503A compounding pharmacy
Those numbers come from SURMOUNT-5, published in the New England Journal of Medicine
Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RA) are effective therapies for patients with type 2 diabetes (T2D) and/or obesity, particularly for those with coexisting cardiovascular disease and/or high cardiovascular risk [1]
Mitrovi T, Stamenkovi S, Cvetkovi V, Radulovi N, Mladenovi M, Stankovi M, Topuzovi M, Radojevi I, Stefanovi O, Vasi S, Comi L (2014) Platismatia glaucia and Pseudevernia furfuracea lichens as sources of antioxidant, antimicrobial and antibiofilm agents
salmon with mango salsa